Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 6.45% vs 29.90% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs -14.16% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 42.74% vs 77.92% in Mar 2024
Compare Balance Sheet Results of Asston Pharmaceu
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
6.27
11.56
-5.29
-45.76%
Share Warrants & Outstandings
Total Reserve
4.76
31.16
-26.40
-84.72%
Shareholder's Funds
11.04
42.72
-31.68
-74.16%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.26
0.93
1.33
143.01%
Secured Loans
0.80
0.00
0.80
0.00%
Unsecured Loans
1.45
0.93
0.52
55.91%
Deferred Tax Assets / Liabilities
-0.02
-0.03
0.01
33.33%
Other Long Term Liabilities
0.16
0.05
0.11
220.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
2.39
0.95
1.44
151.58%
Current Liabilities
Trade Payables
5.97
1.25
4.72
377.60%
Other Current Liabilities
3.70
3.27
0.43
13.15%
Short Term Borrowings
5.00
0.11
4.89
4,445.45%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
14.67
4.63
10.04
216.85%
Total Liabilities
28.10
48.30
-20.20
-41.82%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.10
8.36
-7.26
-86.84%
Less: Accumulated Depreciation
0.14
2.39
-2.25
-94.14%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.96
5.96
-5.00
-83.89%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.68
-0.68
-100.00%
Long Term Loans & Advances
0.00
8.39
-8.39
-100.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
0.96
15.03
-14.07
-93.61%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.72
12.90
-12.18
-94.42%
Sundry Debtors
24.55
9.47
15.08
159.24%
Cash and Bank
0.20
3.42
-3.22
-94.15%
Other Current Assets
0.14
1.77
-1.63
-92.09%
Short Term Loans and Advances
1.55
5.72
-4.17
-72.90%
Total Current Assets
27.15
33.28
-6.13
-18.42%
Net Current Assets (Including Current Investments)
12.47
28.65
-16.18
-56.47%
Total Current Assets Excluding Current Investments
27.15
33.28
-6.13
-18.42%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
28.10
48.30
-20.20
-41.82%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.26
1.04
6.22
598.08%
Book Value per share (adjusted)
17.60
36.14
-18.54
-51.30%
Annual - Borrowings
Borrowings 7.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs 29.90% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs -14.16% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 27.15 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 42.74% vs 77.92% in Mar 2024






